|
|
Cardiometabolic Health Congress 2009 is a vital medical education conference that will aim to assemble US based practicing clinicians. The congress will provide an unparalleled opportunity for clinicians to explore the latest practical strategies to avoid, delay and manage cardiometabolic risk. The CMHC 2009 will deliver the current strategies for prevention, analysis and management of type 2 diabetes, atherosclerosis, hypertension, chronic kidney disease, obesity, dyslipidemia, thrombosis and related comorbidities.
The Cardiometabolic Health Congress 2009 (CMHC 2009) will explore the following topics:
- Advances in Peptide Hormone Therapy: Improving the Management of Obesity, Diabetes, and Cardiometabolic Risk Management
- High Dose Insulin Therapy for Patients with T2DM and Severe Insulin Resistance
- Hypertension and CV Risk Reduction: The Role of New Generation Beta Blockade
- Global Cardiometabolic Risk 2009: Where We Are Today
- New Insights into the Pathogenesis of Atherothrombosis
- Late - Breaking Clinical Trials: Implications for Clinical Practice
- Obesity Management: Diet, Lifestyle, Pharmacotherapy, and Surgery
- Advances in the Clinical Management of Obesity: Implications of Therapies in Late-Stage Development
- Advances in Dual Anti-Platelet Therapy: Optimizing Anti-Thrombotic Therapy in Patients with ACS
- Diabetes Management Across the Lifespan
- Clinical Dilemmas in Managing the Hypertensive Patient with Osteoarthritis
- The Relationship between Insulin Resistance and Atherosclerotic Cardiovascular Disease
- Cardiometabolic Risk: A Link to Other Important Conditions
- Biomarkers: New Insights into Inflammation and the Prevention of CVD
- Clinical Controversies in Lipid Management
Organizer
Cardiometabolic Health Congress
